Navigation Links
UNM Cancer Center selected for national clinical trial
Date:5/10/2013

The University of New Mexico Cancer Center is among a few select institutions nationwide participating in a Phase 3 clinical trial studying a novel treatment for men with newly diagnosed, localized prostate cancer.

In most cases, prostate cancer is detected early and eradicated. However, even with early detection, the cancer returns in up to 30% of patients. The trial will study whether combining this innovative treatment with standard radiation therapy will produce an immune response that will kill cancerous cells throughout the body and decrease the likelihood of the tumor ever coming back.

In this study, men receive three injections of an engineered virus directly into the prostate followed by 14 days of oral doses of a medication called valacyclovir. The injection is a viral vehicle, a virus that can't make more of itself, that delivers a specific gene into the cancer cell. Once inside, the gene converts the valacyclovir into an active form causing death of the tumor cell. This process also generates a vaccine response against the cancer that can detect and kill microscopic cancer cells wherever they lurk, helping to prevent the cancer from returning.

Thomas Schroeder, MD, is Medical Director of Radiation Oncology and the institutional principal investigator for the ProstAtak clinical trial at the UNM Cancer Center. He says, "The protocol for this trial is very interesting because it is a new and different approach." Dr. Schroeder is referring to combining this treatment with the standard of care, so that men's bodies have a stimulated immune system more able to detect and kill cancerous cells.

This clinical trial is designed for men with intermediate-risk localized prostate cancercancer that has not spread beyond the prostateor for men with some forms of high risk cancer. "This treatment will hopefully help men who have just been diagnosed with cancer and are trying to decide on a treatment approach," says Dr. Schroede
'/>"/>

Contact: Michele Sequeira
MSequeira@salud.unm.edu
505-925-0486
University of New Mexico Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Voices Against Brain Cancer Commends Woman on How She is Keeping Her Husband’s Memory Alive
2. Cancer drug prevents build-up of toxic brain protein
3. Socializing May Ease Pain of Breast Cancer
4. John Theurer Cancer Center brings leading experts for its Ninth Annual Neuro-Oncology Symposium
5. Research finds identifies social needs of young people with cancer
6. Popular diabetes drug does not improve survival rates after cancer: Study
7. Your immune system: On surveillance in the war against cancer
8. Fun and friends help ease the pain of breast cancer
9. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
10. Just How Might Exercise Lower Breast Cancer Risk?
11. GW receives Patient-Centered Outcomes Research Institute award to evaluate cancer survivorship care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 NCPDP announced today ... Program. The program establishes a three-year commitment of strategic ... of 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder ... of NCPDP, “and this is a wonderful continuation and ... We can trace AmerisourceBergen back to our very first ...
(Date:5/5/2015)... May 05, 2015 Hiliary Critchley, ... will present at the 24th Annual WEDI ... p.m. MT in Scottsdale, AZ. WEDI, the Workgroup ... nonprofit authority on the use of health IT ... Graf, National Director of Telemedicine for UnitedHealthcare will ...
(Date:5/5/2015)... Viverae®, a health management and ... leading multinational developer, manufacturer and marketer of innovative, ... urology, oncology and surgical specialty products, as the ... Vanguard Award recognizes outstanding achievement in the design ... significant client base. , Viverae reviewed the employee ...
(Date:5/5/2015)... 05, 2015 Nutritional science and medical ... a variety of health conditions and illnesses linked to ... to adopt clean eating methods to rid the body ... with over-consumption of fast and processed foods. Patients find ... to follow and report feeling better and losing excess ...
(Date:5/5/2015)... 2015 MAP Health Management, LLC, a ... management for addiction treatment facilities, announced today that Jimmy ... Business Development. Mr. Mooney, who has more than 35 ... be responsible for developing new strategic partnerships with substance ... products and new initiatives. , Prior to joining MAP, ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... , Jan. 15 The March of Dimes has ... mothers and babies in Haiti imperiled by the devastating ... concerned about the thousands of pregnant women and moms caring for ... Dr. Jennifer L. Howse , president of the March of ...
... , Jan. 15 The devastating, 7.0 magnitude earthquake ... situation, particularly for those Haitians living with diabetes. Furthermore, donors ... of the population, such as those victims already living with ... the largest online diabetes community, aims to mobilize its members ...
... ... , ... 15, 2009 -- The United Nations Foundation ,s senior global health expert, Dr. Daniel ... has already met with United Nations staff and will continue to assess the situation on ...
... , , ... wake of this week,s devastating earthquake, premier travel insurance comparison ... LLC ( HCCMIS ) have launched a special initiative providing ... heading to Haiti to aid in relief efforts. ...
... of Dimes Concerned About Drugs, Role in Growing Crisis of Prematurity ... The widespread use of so-called fertility drugs, ... previously realized in the growing problem of premature births in ... of multiple births, the March of Dimes said today. , The ...
... WASHINGTON , Jan. 15 Today the National ... System as the recipient of the 2010 NQF National Quality ... patient-centered healthcare. The award – the first presented to a ... presented in partnership with Modern Healthcare on ...
Cached Medicine News:Health News:March of Dimes Supports Urgent Needs of Mothers and Babies in Haiti Earthquake 2Health News:dLife Connects Largest Online Diabetes Community to Facilitate Aid to Haitian Earthquake Victims Suffering From Diabetes 2Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 2Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 3Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 2Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 3Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 4Health News:Fertility Drugs Contribute Heavily to Multiple Births 2Health News:Fertility Drugs Contribute Heavily to Multiple Births 3Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 2Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 3Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 4
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
(Date:5/5/2015)... 05, 2015 Research and Markets ... the "Clinical Laboratory,Molecular Diagnostics and Genomic Testing ... - Asia Pacific Version" report to their ... on growing. Clinical laboratory testing is positioned to ... genomics. A range of dynamic trends are pushing ...
(Date:5/5/2015)... are coming up with brilliant ways to help cannabis business solve problems and capitalize on opportunities. However not every idea makes ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150504/213635-INFO ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4
... and National HIV/AIDS Elimination Act, NEW YORK, Oct. ... of,advancing prophetic social justice ministry, Black clergy are stepping,forward ... theologically,sound HIV/AIDS public policy. Working with the National Black ... up to the biblical,mandate that calls us to be ...
... Patient Subgroup Will Assess Safety and Anti-Viral ... ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... infection (HCV), today announced that the first patient,has been dosed in ...
Cached Medicine Technology:Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 3Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 2Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 3Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 4
... an immunoradiometric assay designed,for the ... serum. It is,intended strictly for ... of,two contexts:, (a) serial measurements ... patients with,nonseminomatous testicular cancer and,other ...
Enzyme immunoassay for the quantitative determination of ovarian cancer antigen CA125 in human serum...
Test for prostatic acid phosphatase...
... iMRI is a neurosurgical OR that ... diagnostic tools, including iMRI, necessary to ... iMRI, neurosurgical treatments are performed in ... designed for MR compatibility and safety, ...
Medicine Products: